| abstract |
【Task】 In this application, chimeric, humanized, affinity maturation, enhanced stability, and bispecific anti-GD2 antibodies and fragments thereof are described. Also provided are methods of using individual antibodies or compositions thereof for GD2-related diseases, particularly neuroblastoma deletion, prevention, and / or therapeutic treatment. [Selection figure] None |